Literature DB >> 19128816

Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3.

Cyril Le Nouën1, Shirin Munir, Stéphanie Losq, Christine C Winter, Thomas McCarty, David A Stephany, Kevin L Holmes, Alexander Bukreyev, Ronald L Rabin, Peter L Collins, Ursula J Buchholz.   

Abstract

Human respiratory syncytial virus (HRSV), human metapneumovirus (HMPV), and human parainfluenza virus type 3 (HPIV3) are common, important respiratory pathogens, but HRSV has a substantially greater impact with regard to acute disease, long-term effects on airway function, and frequency of re-infection. It has been reported to strongly interfere with the functioning of dendritic cells (DC). We compared HRSV to HMPV and HPIV3 with regard to their effects on human monocyte-derived immature DC (IDC). Side-by-side analysis distinguished between common effects versus those specific to individual viruses. The use of GFP-expressing viruses yielded clear identification of robustly infected cells and provided the means to distinguish between direct effects of robust viral gene expression versus bystander effects. All three viruses infected inefficiently based on GFP expression, with considerable donor-to donor-variability. The GFP-negative cells exhibited low, abortive levels of viral RNA synthesis. The three viruses induced low-to-moderate levels of DC maturation and cytokine/chemokine responses, increasing slightly in the order HRSV, HMPV, and HPIV3. Infection at the individual cell level was relatively benign, such that in general GFP-positive cells were neither more nor less able to mature compared to GFP-negative bystanders, and cells were responsive to a secondary treatment with lipopolysaccharide, indicating that the ability to mature was not impaired. However, there was a single exception, namely that HPIV3 down-regulated CD38 expression at the RNA level. Maturation by these viruses was anti-apoptotic. Inefficient infection of IDC and sub-optimal maturation might result in reduced immune responses, but these effects would be common to all three viruses rather than specific to HRSV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19128816      PMCID: PMC2668876          DOI: 10.1016/j.virol.2008.11.043

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  61 in total

1.  CD38 is expressed on human mature monocyte-derived dendritic cells and is functionally involved in CD83 expression and IL-12 induction.

Authors:  Giorgio Fedele; Loredana Frasca; Raffaella Palazzo; Enza Ferrero; Fabio Malavasi; Clara Maria Ausiello
Journal:  Eur J Immunol       Date:  2004-05       Impact factor: 5.532

2.  Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium.

Authors:  Liqun Zhang; Alexander Bukreyev; Catherine I Thompson; Brandy Watson; Mark E Peeples; Peter L Collins; Raymond J Pickles
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Morbidity associated with the major respiratory viruses.

Authors:  W P Glezen
Journal:  Pediatr Ann       Date:  1990-09       Impact factor: 1.132

4.  Live respiratory syncytial virus vaccine administered parenterally.

Authors:  E B Buynak; R E Weibel; A A McLean; M R Hilleman
Journal:  Proc Soc Exp Biol Med       Date:  1978-04

5.  Order of transcription of genes of vesicular stomatitis virus.

Authors:  L A Ball; C N White
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

6.  Human monocyte isolation methods influence cytokine production from in vitro generated dendritic cells.

Authors:  Eyad Elkord; Paul E Williams; Howard Kynaston; Anthony W Rowbottom
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

7.  Parainfluenza virus bronchiolitis. Epidemiology and pathogenesis.

Authors:  R C Welliver; D T Wong; M Sun; N McCarthy
Journal:  Am J Dis Child       Date:  1986-01

8.  Suppressed expression of ICAM-1 and LFA-1 and abrogation of leukocyte collaboration after exposure of human mononuclear leukocytes to respiratory syncytial virus in vitro. Comparison with exposure to influenza virus.

Authors:  A R Salkind; J E Nichols; N J Roberts
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

9.  Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells.

Authors:  Shirin Munir; Cyril Le Nouen; Cindy Luongo; Ursula J Buchholz; Peter L Collins; Alexander Bukreyev
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

10.  Measles virus suppresses cell-mediated immunity by interfering with the survival and functions of dendritic and T cells.

Authors:  I Fugier-Vivier; C Servet-Delprat; P Rivailler; M C Rissoan; Y J Liu; C Rabourdin-Combe
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

View more
  39 in total

1.  Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.

Authors:  Philippa Hillyer; Viraj P Mane; Aaron Chen; Maria B Dos Santos; Lynnsie M Schramm; Rachel E Shepard; Cindy Luongo; Cyril Le Nouën; Lei Huang; Lihan Yan; Ursula J Buchholz; Ronald G Jubin; Peter L Collins; Ronald L Rabin
Journal:  Virology       Date:  2017-01-31       Impact factor: 3.616

2.  Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection.

Authors:  Daniel S McDermott; Kayla A Weiss; Cory J Knudson; Steven M Varga
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

3.  Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses.

Authors:  Srirupa Chatterjee; Priya Luthra; Ekaterina Esaulova; Eugene Agapov; Benjamin C Yen; Dominika M Borek; Megan R Edwards; Anuradha Mittal; David S Jordan; Parameshwar Ramanan; Martin L Moore; Rohit V Pappu; Michael J Holtzman; Maxim N Artyomov; Christopher F Basler; Gaya K Amarasinghe; Daisy W Leung
Journal:  Nat Microbiol       Date:  2017-06-30       Impact factor: 17.745

4.  Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.

Authors:  Philipp A Ilinykh; Ndongala M Lubaki; Steven G Widen; Lynnsey A Renn; Terence C Theisen; Ronald L Rabin; Thomas G Wood; Alexander Bukreyev
Journal:  J Virol       Date:  2015-05-13       Impact factor: 5.103

Review 5.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

6.  Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus.

Authors:  Cyril Le Nouën; Philippa Hillyer; Eric Levenson; Craig Martens; Ronald L Rabin; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

7.  Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent protein.

Authors:  Shin-Hee Kim; Siba K Samal
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

8.  The lack of maturation of Ebola virus-infected dendritic cells results from the cooperative effect of at least two viral domains.

Authors:  Ndongala M Lubaki; Philipp Ilinykh; Colette Pietzsch; Bersabeh Tigabu; Alexander N Freiberg; Richard A Koup; Alexander Bukreyev
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

9.  Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells.

Authors:  Cyril Le Nouën; Philippa Hillyer; Shirin Munir; Christine C Winter; Thomas McCarty; Alexander Bukreyev; Peter L Collins; Ronald L Rabin; Ursula J Buchholz
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

10.  Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells.

Authors:  Pablo F Céspedes; Pablo A Gonzalez; Alexis M Kalergis
Journal:  Immunology       Date:  2013-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.